X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Concomitant inhibition of PPARγ and mTORC1 induces the differentiation of human monocytes into highly immunogenic dendritic cells.

Fernando Erra Diaz | Ignacio Mazzitelli | Lucía Bleichmar | Claudia Melucci | Asa Thibodeau | Tomás Dalotto Moreno | Radu Marches | Gabriel A Rabinovich | Duygu Ucar | Jorge Geffner
Cell reports | 2023

Monocytes can differentiate into macrophages (Mo-Macs) or dendritic cells (Mo-DCs). The cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the differentiation of monocytes into Mo-Macs, while the combination of GM-CSF/interleukin (IL)-4 is widely used to generate Mo-DCs for clinical applications and to study human DC biology. Here, we report that pharmacological inhibition of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) in the presence of GM-CSF and the absence of IL-4 induces monocyte differentiation into Mo-DCs. Remarkably, we find that simultaneous inhibition of PPARγ and the nutrient sensor mammalian target of rapamycin complex 1 (mTORC1) induces the differentiation of Mo-DCs with stronger phenotypic stability, superior immunogenicity, and a transcriptional profile characterized by a strong type I interferon (IFN) signature, a lower expression of a large set of tolerogenic genes, and the differential expression of several transcription factors compared with GM-CSF/IL-4 Mo-DCs. Our findings uncover a pathway that tailors Mo-DC differentiation with potential implications in the fields of DC vaccination and cancer immunotherapy.

Pubmed ID: 36842088 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


beta Actin Loading Control Monoclonal Antibody (BA3R) (antibody)

RRID:AB_2537660

This monoclonal targets beta Actin Loading Control

View all literature mentions

Phospho-p70 S6 Kinase (Thr389) Antibody (antibody)

RRID:AB_330944

This polyclonal targets Phospho-p70 S6 Kinase (Thr389)

View all literature mentions

PE anti-human CD207 (Langerin) (antibody)

RRID:AB_10897451

This monoclonal targets CD207

View all literature mentions

HLA-DR, DP, DQ (antibody)

RRID:AB_10897011

This monoclonal targets HLA-DR, DP, DQ

View all literature mentions

CD80 (antibody)

RRID:AB_10565975

This monoclonal targets CD80 (B7-1)

View all literature mentions